Evidence-Based Cannabis Medicine: Insights from Global Clinical Research
- GREEN CAVE

- Nov 20, 2025
- 2 min read
Updated: Jun 23
We are pleased to present a scientific overview of the research conducted by Dr. Lihi Bar-Lev Schleider, a clinical researcher with over 17 years of experience in medical cannabis studies. Her work includes large-scale real-world patient data analyses and several randomized placebo-controlled clinical trials conducted in collaboration with hospitals, research institutes, and clinical partners internationally.
Dr. Bar-Lev Schleider’s Research Focus
Dr. Bar-Lev Schleider’s research focuses on evidence-based evaluation of cannabinoids across a range of clinical domains, including:
Neurological and neurodevelopmental conditions
Chronic and neuropathic pain
PTSD and trauma-related symptoms
Inflammatory and autoimmune disorders
Her studies have contributed to a clearer understanding of patient outcomes, safety considerations, and therapeutic response patterns in both real-world and controlled clinical settings.

Why This Research Matters
As medical cannabis enters a more regulated and clinically oriented era, healthcare professionals and industry partners increasingly rely on validated, scientifically grounded information. Evidence-based data—rather than commercial claims—are essential for guiding safe, responsible, and compliant medical-cannabis practices.
The Importance of Evidence-Based Data
Evidence-based data plays a crucial role in advancing the medical cannabis field. It helps to ensure that patients receive the best possible care based on scientific findings. This approach minimizes risks and maximizes therapeutic benefits.
At Green Cave, we are committed to sharing educational, non-commercial, and regulation-aligned scientific content to support Thailand’s evolving medical-cannabis ecosystem and the global community of clinicians, researchers, and B2B professionals.
Expanding the Understanding of Medical Cannabis
The Role of Cannabinoids
Cannabinoids are the active compounds found in cannabis. They interact with the body’s endocannabinoid system, which plays a vital role in regulating various physiological processes. Understanding how cannabinoids work can help in developing effective treatments for various conditions.
Clinical Trials and Their Impact
Clinical trials are essential for validating the efficacy and safety of medical treatments. Dr. Bar-Lev Schleider's randomized placebo-controlled trials provide critical insights. They help establish the therapeutic potential of cannabinoids and guide healthcare providers in making informed decisions.
Patient-Centric Research
Research that centers on patient experiences is vital. It helps identify the real-world impact of medical cannabis on quality of life. By focusing on patient outcomes, researchers can tailor treatments to meet individual needs more effectively.
To explore more of Dr. Bar-Lev Schleider’s research and publications, visit her profile: https://linkedin.com/in/lihi-bar-lev-schleider-120bb68b.
Are you a licensed clinic or dispensary in Thailand looking for consistent, medical-grade GACP strains? We support regulated B2B supply only.
Yes — we are sourcing GACP medical cannabis
Yes — we need a compliant B2B supplier in Thailand
Not yet — but evaluating medical cannabis partners
.png)

Comments